These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 19900864)

  • 1. Human immunodeficiency virus-associated lung carcinoma presenting as cutaneous metastases.
    Hamdan A; Dezube BJ; Pantanowitz L
    Clin Lung Cancer; 2009 Nov; 10(6):441-4. PubMed ID: 19900864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human immunodeficiency virus-associated primary lung cancer in the era of highly active antiretroviral therapy: a multi-institutional collaboration.
    D'Jaen GA; Pantanowitz L; Bower M; Buskin S; Neil N; Greco EM; Cooley TP; Henry D; Stem J; Dezube BJ; Stebbing J; Aboulafia DM
    Clin Lung Cancer; 2010 Nov; 11(6):396-404. PubMed ID: 21062730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-AIDS-defining cancers: should antiretroviral therapy be initiated earlier?
    Cinti SK; Gandhi T; Riddell J
    AIDS Read; 2008 Jan; 18(1):18-20, 26-32. PubMed ID: 18240449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy.
    Cheung MC; Pantanowitz L; Dezube BJ
    Oncologist; 2005; 10(6):412-26. PubMed ID: 15967835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994-1998.
    Louie JK; Hsu LC; Osmond DH; Katz MH; Schwarcz SK
    J Infect Dis; 2002 Oct; 186(7):1023-7. PubMed ID: 12232845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of screening guidelines for non-AIDS-defining malignancies: evolving issues in the era of highly active antiretroviral therapy.
    Tyerman Z; Aboulafia DM
    AIDS Rev; 2012; 14(1):3-16. PubMed ID: 22297500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.
    Bonnet F; Lewden C; May T; Heripret L; Jougla E; Bevilacqua S; Costagliola D; Salmon D; Chêne G; Morlat P
    Cancer; 2004 Jul; 101(2):317-24. PubMed ID: 15241829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary esophageal carcinoma in the era of highly active antiretroviral therapy.
    Stebbing J; Krown SE; Bower M; Batra A; Slater S; Serraino D; Dezube BJ; Dhir AA; Pantanowitz L
    Arch Intern Med; 2010 Jan; 170(2):203-7. PubMed ID: 20101017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression of HIV infection in the post-HAART era among a cohort of HIV+ Greek haemophilia patients.
    Katsarou O; Touloumi G; Antoniou A; Kouramba A; Hatzakis A; Karafoulidou A
    Haemophilia; 2005 Jul; 11(4):360-5. PubMed ID: 16011588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of human herpesvirus 8 infection and interferon-gamma response in cutaneous lesions of Kaposi sarcoma differ among human immunodeficiency virus-infected and uninfected individuals.
    Guedes F; de Andrade HF; Fernandes ER; Tuon FF; Brasil RA; Pagliari C; Duarte MI
    Br J Dermatol; 2008 Sep; 159(4):839-46. PubMed ID: 18644020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
    Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
    J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed progression to death and to AIDS in a Hong Kong cohort of patients with advanced HIV type 1 disease during the era of highly active antiretroviral therapy.
    Wong KH; Chan KC; Lee SS
    Clin Infect Dis; 2004 Sep; 39(6):853-60. PubMed ID: 15472819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Setting a minimum threshold CD4 count for initiation of highly active antiretroviral therapy in HIV-infected patients.
    Ho C; Lee S; Wong Kh; Cheng L; Lam M
    HIV Med; 2007 Apr; 8(3):181-5. PubMed ID: 17461862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous metastases as the first clinical sign of metastatic gastric carcinoma.
    Frey L; Vetter-Kauczok C; Gesierich A; Bröcker EB; Ugurel S
    J Dtsch Dermatol Ges; 2009 Oct; 7(10):893-895. PubMed ID: 19538484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence, associated factors, and prognostic determinants of AIDS-related toxoplasmic encephalitis in the era of advanced highly active antiretroviral therapy.
    Antinori A; Larussa D; Cingolani A; Lorenzini P; Bossolasco S; Finazzi MG; Bongiovanni M; Guaraldi G; Grisetti S; Vigo B; Gigli B; Mariano A; Dalle Nogare ER; De Marco M; Moretti F; Corsi P; Abrescia N; Rellecati P; Castagna A; Mussini C; Ammassari A; Cinque P; d'Arminio Monforte A;
    Clin Infect Dis; 2004 Dec; 39(11):1681-91. PubMed ID: 15578371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous metastasis of lung carcinoma: a retrospective study of 12 cases.
    Dhambri S; Zendah I; Ayadi-Kaddour A; Adouni O; El Mezni F
    J Eur Acad Dermatol Venereol; 2011 Jun; 25(6):722-6. PubMed ID: 20735519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin infections in HIV-infected individuals in the era of HAART.
    Rodgers S; Leslie KS
    Curr Opin Infect Dis; 2011 Apr; 24(2):124-9. PubMed ID: 21169832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [AIDS associated cancers in the era of highly active antiretroviral therapy (HAART)].
    Tserenpuntsag B; Kołacińska A; Jabłonowska E
    Przegl Epidemiol; 2007; 61(3):529-34. PubMed ID: 18069390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals.
    Burgi A; Brodine S; Wegner S; Milazzo M; Wallace MR; Spooner K; Blazes DL; Agan BK; Armstrong A; Fraser S; Crum NF
    Cancer; 2005 Oct; 104(7):1505-11. PubMed ID: 16104038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin metastases from lung cancer.
    Mollet TW; Garcia CA; Koester G
    Dermatol Online J; 2009 May; 15(5):1. PubMed ID: 19624979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.